This study is closed for recruitment and publication is in progress.
Recruitment for this study is from patients who voluntarily visit TrueNorth Health Center. We are not accepting outside inquiries for enrollment.
This study will assess the safety and feasibility of water-only fasting and refeeding for treatment of stage 1 and 2 hypertensive patients. Preliminary research suggests that water-only fasting efficiently lowers blood pressure and may effectively improve implementation of and adherence to lifestyle changes. Mean changes in resting blood pressure as well as markers of cardiovascular health and inflammation between baseline and end-of-fast, end-of-refeed, and six-weeks post departure will also be reported. https://clinicaltrials.gov/ct2/show/NCT04515095
Principle Investigators: Toshia Myers, PhD, Eugene L Scharf, MD and Alan Goldhamer, DC
Project Staff: Justin Wise, ND; Natasha Thompson, ND; Evelyn Zeiler, PhD; Sahmla Gabriel, MD; Mara Gilbert, RN; Faye Alexandrakis, DC; Haley Ramsey, MS; Rie Schur, ND; Ahmed Deen